Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Arthritis and Rheumatism|May 28, 2010
Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritisLuis Martinez-Lostao, Felícito García-Alvarez, Gorka Basáñez, et al.
Oncotarget|April 19, 2016
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing proteinAlberto Bosque, Lisa Dietz, Ana Gallego-Lleyda, et al.
Biochemical Pharmacology|November 26, 2013
Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumorsAdriana Aporta, Elena Catalán, Patricia Galán-Malo, et al.
Molecular Oncology|September 13, 2023
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X<sub>L</sub> in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patientsManuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez, et al.
Oncoimmunology|May 8, 2015
Human NK cells activated by EBV<sup>+</sup> lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cellsDiego Sánchez-Martínez, Gemma Azaceta, Aura Muntasell, et al.
Oncoimmunology|November 7, 2022
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosisAlfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, et al.
Oncoimmunology|January 18, 2021
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patientsChantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-de-Maudave, et al.
Scientific Reports|November 11, 2020
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistanceTania Calvo, Chantal Reina-Ortiz, David Giraldos, et al.
Oncoimmunology|September 25, 2025
NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells <i>ex vivo</i> and <i>in vivo</i>, especially if combined with daratumumabDavid Giraldos, Evelyn Galano-Frutos, Laura Cambronero-Arregui, et al.
Pageof 5